Drug Research
Union therapeutics signs deal with Innovent to develop orismilast in China
Union therapeutics has signed a strategic partnership and license agreement with Innovent Biologics to develop and commercialise its therapy, orismilast, in China.
A potent and selective next-generation PDE4 inhibitor for inflammatory dermatology conditions, orismilast possesses extensive anti-inflammatory properties.
Developed originally by...
News
Paradigm4 launches flexFS for high throughput and resource efficient management for life science and healthcare data in the cloud
Paradigm4, an integrated scientific data analytics company, has launched flexFS TM , its innovative, elastic cloud file system for flexible and more resource efficient data storage and scalable computing.
flexFS increases data agility and reduces the costs of working with...
News
Peli BioThermal Launches Updated Website
Peli BioThermal, the global name in temperature controlled packaging solutions, announces the launch of its newly designed website. Located at www.pelibiothermal.com, the new site offers a wide variety of resources to support the worldwide business of its life sciences...
News
Government Lauds Indian Immunologicals Ltd for Efforts in Producing COVID-19 Drug Substance in record time
Union Fisheries, Animal Husbandry, and Dairying Minister, Mr. Parshottam Rupala lauded the efforts of Indian Immunologicals Limited (IIL) for their ability to roll out Covid-19 vaccine drug substance in record time.
Indian Immunologicals Ltd (IIL) has quickly responded to the...
News
Brooks Introduces Azenta Life Sciences To Advance Innovative Sample Solutions
Brooks Automation, Inc. announces Brooks Life Sciences Services and Products businesses will be rebranded under the creation of a new identity – Azenta Life Sciences. Azenta will bring together our existing portfolio of life sciences products and services to...
News
First customer boards Recipharm’s soft mist inhaler technology platform
Resyca, Recipharm’s joint venture with Medspray, has boarded its first pharmaceutical customer on the soft mist inhaler (SMI) platform. An agreement has been signed involving milestones and royalties for exclusivity on the specific drug product.
The innovative SMI platform consists...
News
Gamma Biosciences Makes Strategic Investment in Process Analytics and Continuous Bioprocessing Company, Nirrin Technologies
Gamma Biosciences, a global life sciences company serving the advanced therapy market, today announced a strategic investment in Nirrin Technologies, a provider of next generation sensors and analytics for real-time, in-process monitoring and analysis in upstream and downstream bioprocessing...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















